Syed A. v. Commissioner of Social Security

CourtDistrict Court, S.D. New York
DecidedMarch 31, 2026
Docket1:25-cv-02051
StatusUnknown

This text of Syed A. v. Commissioner of Social Security (Syed A. v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Syed A. v. Commissioner of Social Security, (S.D.N.Y. 2026).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ----------------------------------------------------------------x SYED A., : : 25 Civ. 2051 (GS) Plaintiff, : : OPINION AND ORDER - against - : : COMMISSIONER OF SOCIAL SECURITY, : : Defendant. : ----------------------------------------------------------------x GARY STEIN, United States Magistrate Judge: Plaintiff Syed A. (“Syed” or “Plaintiff”) seeks judicial review, pursuant to 42 U.S.C. §§ 405(g) and 1383(c)(3), of a final determination of the Commissioner of Social Security (the “Commissioner”) denying his claims for social security disability benefits and supplemental security income benefits. Plaintiff moves for judgment on the pleadings pursuant to Fed R. Civ. P. 12(c). (Dkt. No. 13). For the reasons set forth below, Plaintiff’s motion is DENIED and the Commissioner’s determination is AFFIRMED. BACKGROUND A. Procedural History On November 8, 2022, Syed filed applications for Social Security Disability (“SSD”) benefits under Title II of the Social Security Act and for Supplemental Security Income (“SSI”) benefits under Title XVI of the Social Security Act, and alleged a disability onset date of October 20, 2022. (Dkt. No. 10, Administrative Record (“AR”) 199-218). The Social Security Administration (“SSA”) initially denied Syed’s applications on March 30, 2023 (AR 84-94), and again after reconsideration on October 19, 2023 (AR 104-19). Syed requested a hearing before an Administrative Law Judge (“ALJ”) on November 6, 2023. (AR 120-21). A hearing was conducted before ALJ Kimberly D. Schulz on May 23, 2024.

(AR 31-51). In a decision issued on June 11, 2024 (the “ALJ Decision”), ALJ Schulz found that Syed was not disabled within the meaning of the Social Security Act and thus denied both of his applications for benefits. (AR 14-30). On January 15, 2025, the Appeals Council denied Syed’s request for review of the ALJ Decision, which thus became the Commissioner’s final decision. (AR 1-6). Syed filed his Complaint, seeking review of the ALJ Decision, on March 12, 2025. (Dkt. No. 1). Syed moved for judgment on the pleadings on August 14, 2025.

(Dkt. No. 13, 14 (“Pl. Br.”) (memorandum of law)). The Commissioner filed a brief on September 24, 2025 opposing Syed’s motion and requesting that the Commissioner’s final decision be affirmed. (Dkt. No. 15 (“Gov. Br.”)). B. Administrative Record Syed was 52 years old when he applied for SSD and SSI benefits in 2022. (AR 201). He studied up to fifth grade in Bangladesh, with no further education in

the United States. (AR 38). His only prior relevant work experience is as a cook’s helper. (AR 45). He last worked in April 2020 when the COVID-19 pandemic began. (AR 202). Although Syed claimed disability based on several conditions (see AR 52, 62), the ALJ found his only severe impairments to be diabetes mellitus and multilevel spondylosis; his other claimed impairments, the ALJ found, are non-severe and do not limit his ability to perform work activities. (AR 19-20 (finding that Syed’s H Pylori infection, retinopathy, kidney disease, lung impairment, and hyperlipidemia are non-severe impairments)). Syed does not challenge those findings and hence

this opinion focuses on Syed’s severe impairments. Syed has an extensive record of treatment for Type 2 diabetes mellitus with hypo and hyperglycemia. He was originally diagnosed with diabetes in 2004. (AR 1828). On January 8, 2020, a physician noted that Syed had “[u]ncontrolled type 2 diabetes mellitus with both eyes affected by mild nonproliferative retinopathy without macular edema, with long-term current use of insulin.” (AR 641). At that time, he was prescribed, inter alia, 18 units of insulin glargine nightly. (AR 642).

Notes from a primary care visit on March 24, 2022 indicate that his diabetes remained uncontrolled despite an increase in his insulin dosage to 55 units nightly. (AR 745-46). Notes from a May 6, 2022 visit indicate that his condition persisted. (AR 721-22). On August 6, 2022, Syed was hospitalized at Bronx Lebanon Hospital for low blood sugar and altered mental state, charted as requiring “immediate life-saving

intervention.” (AR 365-66). During his hospitalization, Syed tested positive for COVID-19, and a physician noted this as a potential cause of an acute kidney injury leading to low blood sugar. (AR 378-79). At that time, Syed was taking insulin, metformin, and alogliptin for his diabetes. (AR 418). After a six-day stay, he was stabilized and discharged on August 12, 2022. (AR. 566). His use of insulin and alogliptin was discontinued, though he continued to take metformin. (AR 890, 758). His family suggested that this was his first episode of hypoglycemia. (AR 1405). Syed did not express any complaints at the time of his discharge. (AR 643). On August 31, 2022, Syed had an initial evaluation with Metropolitan

Hospital’s endocrinology department. (AR 1401-22). A week before, testing indicated abnormally high glucose and creatinine levels. (AR 712). Syed reported symptoms of numbness/pain/tingling sensations in his hands or feet, had experienced high fasting glucose levels in the 300s following his discharge from Bronx Lebanon Hospital, and presented with a glucose level of 412 during his visit. (AR 1405-06). His diabetes mellitus was assessed as “poorly controlled”; he was re- prescribed insulin (at a dosage of 12 units), and his dosage of alogliptin was

increased. (AR 772, 1411). On September 23, 2022, his insulin dosage was further increased to 13-15 units. (AR 779). An October 11, 2022 evaluation noted that Syed’s diabetes mellitus remained “uncontrolled” despite insulin use, and his dosage was increased to 20 units. (AR 1825-7, 1829). In tests on that date and on October 20, 2022, Syed continued to present elevated glucose levels. (AR 809-10). On October 25, 2022, Syed’s primary

care provider prescribed him Farxiga, but he did not begin using it because it was denied by his health insurance. (AR 766). Syed’s diabetes was assessed as “uncontrolled” during November 15, 2022 and October 10, 2023 evaluations, despite adjustments to his medications, insulin included. (AR 796-99, 2019-20). By contrast, notes from October 17, 2023 and November 14, 2023 evaluations refer to Syed’s diabetes as “controlled.” (AR 1995, 1967). At a January 24, 2023 endocrinologist visit, Syed reported no acute complaints and indicated that he was feeling well. (AR 891). At a February 8, 2023 primary care visit, he reported occasional dizziness and palpitations. (AR 937). At

a February 21, 2023 visit, he denied having numbness/tingling/burning sensations in his feet. (AR 917). The SSA’s Disability Determination Explanation supporting its initial denial of Syed’s application in March 2023 included a medical evaluation from a non- examining state agency consultant, Dr. A. Saeed. (AR 52-55). Dr. Saeed concluded, based on his review of the medical record, that none of Syed’s claimed impairments, including his diabetes, was severe. (AR 54). The evaluation also noted the absence

of any “medical opinion from any medical source.” (Id.). Syed, now represented by counsel, moved for reconsideration. (AR 76-83). This resulted in another Disability Determination Explanation, dated October 17, 2023. (AR 62-67). In that evaluation, another non-examining state agency consultant, Dr. A. Vinluan, again found Syed’s physical impairments to be non- severe and noted the absence of any medical opinion from any medical source. (AR

65-66). The evaluation also noted that examinations with SSA doctors “were scheduled on 6/27/23 and 7/26/23” but that Syed “failed to attend the exams.” (AR 64).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Meadors v. Astrue
370 F. App'x 179 (Second Circuit, 2010)
Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Genier v. Astrue
606 F.3d 46 (Second Circuit, 2010)
Petrie v. Astrue
412 F. App'x 401 (Second Circuit, 2011)
Williams v. Bowen
859 F.2d 255 (Second Circuit, 1988)
Brault v. Social Security Administration
683 F.3d 443 (Second Circuit, 2012)
Selian v. Astrue
708 F.3d 409 (Second Circuit, 2013)
Johnson v. Astrue
563 F. Supp. 2d 444 (S.D. New York, 2008)
Burden v. Astrue
588 F. Supp. 2d 269 (D. Connecticut, 2008)
Alcantara v. Astrue
667 F. Supp. 2d 262 (S.D. New York, 2009)
Lugo v. Apfel
20 F. Supp. 2d 662 (S.D. New York, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Syed A. v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/syed-a-v-commissioner-of-social-security-nysd-2026.